-Reuters
Kentucky Senate Passes Medical Marijuana Legalization Bill
https://twitter.com/MarijuanaMoment/status/1636504218214322178
Related Posts
Raymond James Initiates Coverage On Avidity Biosciences with Strong Buy Rating, Announces Price Target of $29
Raymond James analyst Steven Seedhouse initiates coverage on Avidity Biosciences (NASDAQ:RNA) with a Strong Buy rating and announces Price Target of $29.
Wells Fargo Maintains Overweight on Biogen, Raises Price Target to $350
Wells Fargo analyst Mohit Bansal maintains Biogen (NASDAQ:BIIB) with a Overweight and raises the price target from $265 to $350.
Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders
Enveric Biosciences, Inc. (NASDAQ: ENVB) has announced new research results detailing the development of novel psilocin prodrug derivatives targeting treatment of mental health disorders. A manuscript describing the research has been submitted for peer-reviewed publication and is currently